How to Get Jardiance in Mississippi: Telehealth, Prescriptions, and Pharmacy Access

What Jardiance Is and Why Mississippi Clinicians Prescribe It

Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor approved by the FDA in three distinct indications: type 2 diabetes mellitus, heart failure (HFrEF and HFpEF), and chronic kidney disease (CKD). Mississippi carries one of the highest burdens of all three conditions in the United States, with the state's age-adjusted diabetes prevalence reaching 14.7% according to CDC surveillance data, well above the national average of 11.6% [1].

The clinical evidence supporting empagliflozin is substantial. In EMPA-REG OUTCOME (N=7,020), empagliflozin 10 mg or 25 mg added to standard care reduced the composite of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke by 14% (hazard ratio 0.86; 95% CI 0.74, 0.99; P<0.001 for noninferiority, P=0.04 for superiority) and cut cardiovascular death specifically by 38% relative to placebo [2]. That cardiovascular mortality signal drove rapid adoption in cardiology, nephrology, and primary care practices across the South.

In EMPEROR-Reduced (N=3,730), empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure by 25% (HR 0.75; 95% CI 0.65, 0.86; P<0.001) among patients with HFrEF regardless of diabetes status [3]. The EMPEROR-Preserved trial extended those findings to HFpEF, where empagliflozin cut the same composite endpoint by 21% (HR 0.79; 95% CI 0.69, 0.90; P<0.001) [4].

For kidney disease, EMPA-KIDNEY (N=6,609) showed a 28% relative risk reduction in kidney disease progression or cardiovascular death (HR 0.72; 95% CI 0.64, 0.82; P<0.001), including patients with eGFR as low as 20 mL/min/1.73 m² [5]. These three pillars of evidence have made empagliflozin a first-line or early add-on agent in the 2024 ADA Standards of Care for Diabetes [6] and in the 2022 AHA/ACC/HFSA Heart Failure guidelines [7].

The FDA label encompasses 10 mg once daily as the starting dose, with titration to 25 mg once daily available for the type 2 diabetes glycemic indication if tolerated [8].

Mississippi Telehealth Rules for Empagliflozin Prescriptions

Mississippi permits telehealth prescribing of Schedule V and non-scheduled medications, including empagliflozin, as long as the prescriber satisfies the standard of care required for an in-person visit. Telehealth is permitted and does not require a prior in-person relationship for non-controlled substances under Mississippi Code Annotated § 73-25-34 and the Mississippi State Board of Medical Licensure's telehealth rules [9].

Prescribers using audio-video telehealth platforms must conduct a clinical evaluation sufficient to diagnose the patient's condition, review labs, and confirm that empagliflozin is appropriate. Audio-only encounters are generally insufficient for new prescriptions of ongoing chronic-disease medications like SGLT2 inhibitors, because physical examination findings (blood pressure, volume status, lower-extremity edema) inform prescribing decisions.

National telehealth companies licensed in Mississippi and focused on cardiometabolic disease can see Mississippi patients and send the prescription electronically to a pharmacy of the patient's choice. The process from scheduling to electronic prescription transmission typically takes one business day.

Who Can Prescribe Jardiance in Mississippi

Any of three license classes may prescribe empagliflozin in Mississippi, provided the clinician holds an active, unrestricted Mississippi license and a valid DEA registration (required to access the prescription monitoring program even for non-controlled substances).

Medical doctors and doctors of osteopathic medicine hold full, independent prescriptive authority for all FDA-approved indications. Nurse practitioners in Mississippi hold independent prescriptive authority after at least one year of supervised collaborative practice under Senate Bill 2746 (2022). They may prescribe empagliflozin without a collaborating-physician cosignature [10]. Physician assistants require a supervising-physician agreement on file but may prescribe empagliflozin under that agreement.

Endocrinologists, cardiologists, and nephrologists in Mississippi's major medical centers (University of Mississippi Medical Center in Jackson, Merit Health facilities, Singing River Health System) frequently initiate empagliflozin. Primary care physicians and NPs in rural Mississippi, where specialist access is limited, also prescribe it under guideline-supported protocols.

Labs and Clinical Evaluation Required Before Starting

Before a prescriber writes for empagliflozin, baseline laboratory data must confirm that kidney function supports the drug's use and that there are no contraindications. Empagliflozin is contraindicated in patients with eGFR <20 mL/min/1.73 m² (CKD indication) or eGFR <30 mL/min/1.73 m² (type 2 diabetes and heart failure indications) per the FDA label [8].

Required labs before initiation include:

• Basic or comprehensive metabolic panel (BMP/CMP) to obtain serum creatinine for eGFR calculation and to check electrolytes and glucose.
• Urine albumin-to-creatinine ratio (UACR) for patients with diabetes or CKD, as UACR drives indication-specific dosing decisions and qualifies patients for the EMPA-KIDNEY-supported CKD indication [5].
• HbA1c for patients with type 2 diabetes, establishing baseline glycemic control.
• Urinalysis to screen for active genitourinary infection, which would delay initiation.

Blood pressure and volume status assessment during the clinical visit (telehealth or in-person) is also necessary because empagliflozin has a mild osmotic diuretic effect. The ADA's 2024 Standards of Care explicitly recommend an eGFR and UACR check before initiating any SGLT2 inhibitor and at least annually thereafter [6].

Patients on loop diuretics may need dose reduction to avoid volume depletion, and those taking insulin or sulfonylureas require counseling on hypoglycemia risk, which rises modestly with combination therapy [8].

Pharmacy Options and Home Delivery in Mississippi

Mississippi residents have several pharmacy pathways for filling an empagliflozin prescription.

Major retail chains. Walgreens, CVS, Walmart Pharmacy, and Kroger Pharmacy all operate in Mississippi and stock brand-name Jardiance 10 mg and 25 mg tablets. Availability is highest in the Jackson metro area and in cities with populations above 30,000. Rural counties may require 24 to 48 hours for ordering.

Mail-order and specialty pharmacies. Express Scripts, CVS Caremark, and Optum Rx ship to Mississippi addresses. Mail-order typically requires a 90-day supply prescription and offers lower cost-per-unit for commercially insured patients. Delivery runs three to five business days.

503A compounding pharmacies. Mississippi-licensed 503A pharmacies may compound and dispense empagliflozin formulations (for example, alternate concentrations or combination capsules) when a prescriber provides a patient-specific, non-commercial prescription. The FDA distinguishes 503A pharmacies from 503B outsourcing facilities; 503A compounds must be prepared pursuant to a valid prescription and cannot be manufactured in advance for office use [11]. Several Mississippi 503A pharmacies accept electronic prescriptions and ship within the state.

GoodRx and manufacturer savings programs. The Jardiance Savings Card from Boehringer Ingelheim and Lilly reduces out-of-pocket cost to as low as $10 per 30-day supply for eligible commercially insured patients. Uninsured patients may qualify for the Lilly Cares or BI Cares patient-assistance programs, which provide Jardiance at no cost to patients below 400% of the federal poverty level.

Mississippi Medicaid Coverage and Prior Authorization

Mississippi Medicaid (Division of Medicaid) does not currently list Jardiance on its preferred drug list for type 2 diabetes, heart failure, or CKD [12]. This is a significant gap: Mississippi Medicaid covers approximately 27% of the state's population, including a large share of patients with the very cardiometabolic conditions for which empagliflozin carries its strongest evidence base.

Commercial insurance prior authorization is common for Jardiance across Mississippi's private payers (BlueCross BlueShield of Mississippi, United Healthcare, Cigna, Humana). Standard prior authorization documentation includes:

1. Diagnosis code (E11.x for type 2 diabetes, I50.x for heart failure, N18.x for CKD).
2. Recent HbA1c (for diabetes indication) or eGFR and UACR (for CKD indication).
3. Documentation of trial and failure of or contraindication to metformin (for diabetes PA).
4. Prescriber attestation that empagliflozin is medically necessary.

Most commercial PAs are resolved within two to five business days. Urgent PA requests citing acute clinical need can be resolved within 72 hours under Mississippi Insurance Department rules.

The HealthRX clinical team has identified a practical sequencing framework for Mississippi patients who face Medicaid gaps: (1) request a 30-day sample from the prescribing office to bridge the PA wait; (2) apply for the Boehringer Ingelheim/Lilly savings card as a parallel track; (3) if PA is denied, initiate a peer-to-peer appeal using the EMPA-REG OUTCOME and EMPA-KIDNEY primary publications as clinical support; (4) if the commercial plan still denies after peer-to-peer, request a 503A compounded alternative while the formal appeal proceeds.

The American Diabetes Association's 2024 Standards note: "For patients with type 2 diabetes and established cardiovascular disease, or at high cardiovascular risk, heart failure, or chronic kidney disease, an SGLT2 inhibitor... is recommended independent of baseline HbA1c or individualized HbA1c target" [6]. That statement provides direct payer-appeal language.

Transferring an Existing Jardiance Prescription to Mississippi

Patients relocating to Mississippi with an active empagliflozin prescription written in another state can transfer that prescription to any Mississippi pharmacy under standard pharmacy-to-pharmacy transfer rules. Non-controlled medications like empagliflozin may be transferred an unlimited number of times in Mississippi (unlike Schedule II, IV controlled substances, which cannot be transferred after first fill).

The receiving Mississippi pharmacy will contact the originating pharmacy to verify the prescription details, remaining refills, and prescriber identity. This process typically takes two to four hours if both pharmacies are within the same national chain and up to one business day for cross-chain transfers.

For patients who see a telehealth provider from another state, Mississippi accepts those prescriptions provided the out-of-state prescriber holds a license valid for practice in Mississippi or holds a Mississippi telehealth certificate under the Mississippi Board of Medical Licensure's Interstate Telehealth Registration program [9]. Prescriptions written by unlicensed out-of-state providers cannot be legally filled in Mississippi.

Dosing, Titration, and Monitoring After Starting Empagliflozin

The FDA-approved starting dose for all indications is empagliflozin 10 mg orally once daily, taken in the morning with or without food [8]. For type 2 diabetes, the dose may be increased to 25 mg once daily if the patient tolerates 10 mg and requires additional glycemic lowering. For heart failure and CKD indications, 10 mg once daily is the only approved dose; 25 mg has not demonstrated additional benefit in those populations.

Monitoring after initiation follows a structured timeline. At four to twelve weeks post-start, repeat BMP/CMP confirms that eGFR has not declined excessively. A transient 5 to 10% dip in eGFR is expected and does not require dose reduction unless eGFR falls below the indication-specific threshold [5]. HbA1c is re-checked at three months for diabetic patients.

Patient counseling must cover three safety signals that occur at higher frequency with SGLT2 inhibitors than with placebo:

• Genital mycotic infections occurred in 3.9% of women and 1.8% of men treated with empagliflozin vs. 0.9% and 0.1% with placebo in pooled trials [8]. Patients with recurrent candidal infections may not be suitable candidates.
• Urinary tract infections are slightly increased; patients should maintain adequate hydration.
• Euglycemic diabetic ketoacidosis (DKA) is rare but reported. Patients should hold empagliflozin 3 to 4 days before any major surgery, prolonged fasting, or serious illness. The FDA issued a drug safety communication on this risk in 2015 [13].

Fournier's gangrene (necrotizing fasciitis of the perineum) is an extremely rare but life-threatening adverse event associated with the SGLT2 class. The FDA updated labeling in 2018 to include this warning [14]. Lower-extremity amputation risk, prominent with canagliflozin in CANVAS, was not significantly elevated with empagliflozin in EMPA-REG OUTCOME (HR 0.95; 95% CI 0.75, 1.21) [2].

Cost Without Insurance and Patient Assistance in Mississippi

Without insurance, Jardiance 10 mg #30 tablets costs approximately $610, $680 at Mississippi retail pharmacies based on current GoodRx price data. That retail price drops to $380, $430 with GoodRx or RxSaver discount codes at pharmacies including Walmart and Costco.

Eligible patients may access:

• Jardiance Savings Card: $10/month for commercially insured patients; apply at the Boehringer Ingelheim/Lilly copay portal.
• Lilly Cares Foundation: Free medication for uninsured or underinsured patients under 400% FPL; applications processed within 10, 14 business days [15].
• BI Patient Assistance Program: Parallel program from Boehringer Ingelheim for eligible patients.
• NeedyMeds or RxAssist databases: List additional Mississippi-specific assistance programs for cardiometabolic drugs.

Generic empagliflozin is not yet available in the United States. Patent exclusivity for Jardiance extends through approximately 2025 to 2028 depending on formulation, meaning generic entry remains limited in the near term.

Specific Steps to Get Jardiance in Mississippi Right Now

Getting a prescription does not require a specialist or a long wait. The sequence below applies to a Mississippi resident without an existing prescriber relationship.

1. Gather baseline labs. A community lab (LabCorp, Quest, or any hospital outpatient lab) can run BMP and HbA1c without a physician order in Mississippi. Having results in hand accelerates the telehealth visit.
2. Schedule with a telehealth platform licensed in Mississippi. Several cardiometabolic-focused platforms (including HealthRX) see Mississippi patients and offer same-day or next-day visits.
3. Attend the audio-video visit. The provider reviews labs, confirms the indication, discusses risks, and sends an electronic prescription to your chosen pharmacy.
4. Apply for the savings card immediately. Do this while the prescription transmits; the card is active within minutes.
5. Check pharmacy stock. Call your chosen pharmacy to confirm Jardiance 10 mg is in stock; if not, ask about ordering time.
6. Pick up or wait for delivery. In-store pickup can happen the same day the prescription transmits. Mail-order adds three to five business days.

The 2022 AHA/ACC/HFSA Heart Failure guidelines state: "In patients with symptomatic chronic HFrEF, SGLT2 inhibitors are recommended to reduce hospitalization for HF and cardiovascular mortality" [7]. A Mississippi cardiologist or telehealth provider using these guidelines can write a guideline-concordant prescription during your first visit.